Choose Your Language:

• 
• 
• 
• 
• 
• 

You are here > Sepha > News > SEPHA THRIVES DESPITE DOWNTURN

SEPHA THRIVES DESPITE DOWNTURN

UK Based Machinery Manufacturer, SEPHA, Thrives Despite Downturn

The private equity backed manufacturing firm, Sepha, has bucked the economic downturn with a

33% increase in sales for 2009. Sepha Ltd which is based in Northern Ireland, manufactures

innovative non-destructive leak testing, deblistering and lab-scale blister packing machines for

the pharmaceutical industry. Much of its growth has come from export markets, particularly the

low labour cost economies of India, Asia and South America.

 

January 21, 2010 -- A UK manufacturing company has bucked the economic downturn with an increase

in sales of 33% in 2009*. Sepha Ltd which is based in Northern Ireland, manufactures innovative

non-destructive leak testing, deblistering and lab-scale blister packing machines for the pharmaceutical industry.

Much of its growth has come from export markets, particularly the low labour cost economies of India, Asia and

South America. Sepha's Chief Executive, Aubrey Sayers, explains "Markets such as India and China offer a

lower manufacturing cost base for western pharma companies, but when it comes to pharmaceuticals, the

emphasis must still be on production quality. Sepha's machines offer an automated way of checking the quality of drug packaging which further saves on production costs."

Within western economies Sepha has also been able to take advantage of the drive by its customers to reduce

waste and disposal costs. Sepha's innovative machines safely remove valuable product from defective packs,

allowing them to be repackaged and sold on to the customer. In addition its range of leak testing machines, which

are used to detect holes in pharmaceutical blister packs, sachets and pouches, offer a clean, non-destructive

alternative to the widely used and messy methylene blue dye leak test which results in unnecessary waste of

valuable product, whether the packaging is defective or not.

Sepha is already doing business with many of the world's top pharmaceutical manufacturers including Boots,

Bayer and Wyeth. It has been designing and building machines in Northern Ireland since 1980. A number of

internal factors including a focused investment in international sales and marketing and an increase in production

capacity combined with the cost saving nature of its machines have allowed Sepha to achieve this growth in

adverse market conditions.

 

Contact Information

Sarah Hession

 

 

Sepha Ltd.

http://www.sepha.com

++44(0)28 90484848

Michele Filippi

 

 

MF Communication

http://www.mfcommunication.net

++44(0)28 90769428